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Abstract
Background: Enterocin AS-48 is produced by Enterococcus faecalis S48 to compete with other
bacteria in their environment. Due to its activity against various Gram positive and some Gram
negative bacteria it has clear potential for use as a food preservative. Here, we studied the effect
of enterocin AS-48 challenges on vegetative cells of Bacillus cereus ATCC 14579 by use of
transcriptome analysis.
Results: Of the 5200 genes analysed, expression of 24 genes was found to change significantly after
a 30 min treatment with a subinhibitory bacteriocin concentration of 0.5 μg/ml. Most of up-
regulated genes encode membrane-associated or secreted proteins with putative transmembrane
segments or signal sequences, respectively. One operon involved in arginine metabolism was
significantly downregulated. The BC4206-BC4207 operon was found to be the most upregulated
target in our experiments. BC4206 codes for a PadR type transcriptional regulator, while BC4207
codes for a hypothetical membrane protein. The operon structure and genes are conserved in B.
cereus and B. thuringiensis species, but are not present in B. anthracis and B. subtilis. Using real-time
qPCR, we show that these genes are upregulated when we treated the cells with AS-48, but not
upon nisin treatment. Upon overexpression of BC4207 in B. cereus, we observed an increased
resistance against AS-48. Expression of BC4207 in B. subtilis 168, which lacks this operon also
showed increased resistance against AS-48.
Conclusion: BC4207 membrane protein is involved in the resistance mechanism of B. cereus cells
against AS-48.
Background
Bacillus cereus is a Gram positive rod-shaped aerobic,
endospore-forming bacterium. Strains of B. cereus are
widely distributed in the environment, mainly in soil,
from where they easily spread to many types of foods,
especially of vegetable origin, as well as meat, eggs, milk,
and dairy products. This bacterium is one of the leading
causes of food poisoning in the developed world. B. cereus
causes two types of food-borne intoxications. One type is
characterized by nausea and vomiting and abdominal
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cramps and has an incubation period of 1 to 6 hours. This
is the "short-incubation" or emetic form of the disease.
The second type is manifested primarily by abdominal
cramps and diarrhea with an incubation period of 8 to 16
hours. This type is referred to as the "long-incubation" or
diarrheal form of the disease [1,2].
Different strategies may be employed to prevent B. cereus
poisoning, like heating food above 75°C before use to kill
vegetative cells. However, increasing trends for use of
packed foods require new food preservation methods to
increase the safety levels against B. cereus. One of the cur-
rent approaches is the use of antimicrobial peptides
(either alone or in combination with other hurdles) such
as enterocin AS-48 and other bacteriocins [3-5].
Bacteriocins are small, ribosomally-synthesized antimi-
crobial peptides synthesized and used by one bacterium
as to inhibit growth of similar or closely related bacterial
strains [6]. Bacteriocins are categorized in several ways,
e.g. on basis of the producing strain, common resistance
mechanisms, and mechanism of killing. Enterocin AS-48
is a broad-spectrum antimicrobial peptide produced by
Enterococcus faecalis S-48, belonging to Class III of entero-
coccal bacteriocins or enterocins [7]. Enterocin AS-48 is a
70-residue cyclic peptide with a molecular weight of 7.15
kDa [8]. The crystal structure of enterocin AS-48 has been
resolved to 1.4  resolution [9]. It is unique with respect to
its natural cyclic structure in which N and C termini are
linked by a peptide bond. It has been shown that ente-
rocin AS-48 adopts different oligomeric structures accord-
ing to physiochemical conditions: it exists in monomeric
form at pH below 3 and in dimeric form in the pH range
of 4.5 to 8.5. The molecules of AS-48 in the crystal are
arranged in chains of pairs of molecules linked either by
hydrophobic interactions (dimeric form I, abbreviated to
DF-I), or by hydrophilic interactions (dimeric form II,
abbreviated to DF-II). The molecules within the DF-I
interact through the hydrophobic helices H1 and H2. On
the other hand, the hydrophilic surfaces of helices H4 and
H5 are interacting in DF-II.
The mode of action of enterocin AS-48 has been eluci-
dated [10]. This bacteriocin makes pores of an approxi-
mate size of 0.7 nm in the bacterial cytoplasmic
membrane thereby disrupting the proton motive force
and causing cell death [10]. It also shows a secondary,
bacteriolytic effect against some of the target bacteria.
Based on its crystal structure, the proposed mechanism of
action suggests that the two different stages of molecular
association, DF-I and DF-II, are involved in changing from
the water-soluble DF-I to the membrane-bound DF-II
stage at the membrane surface. This transition implies a
90° rotation of each protomer within DF-I, in a way that
the partially hidden hydrophobic helices H1 and H2
become solvent accessible [9]. This would permit AS-48 to
insert into the bacterial membrane.
Although the mechanism of action of enterocin AS-48 has
been studied extensively at physiological and physico-
chemical levels, nothing is known about the responses of
sensitive bacterial cells upon exposure to the bacteriocin.
Previous experiment in our laboratory with AS-48 against
Listeria monocytogenes showed that bacterial cells can be
adapted to AS-48, thereby increasing resistance against
AS-48 [11]. This adaptation can be achieved with subse-
quent inoculation in the presence of low, but still inhibi-
tory concentrations of AS-48. However, the adaptation is
gradually lost upon repeated subcultivation. Given the
great interest of enterocin AS-48 as a food preservative, it
is of high relevance to know how the target bacteria react
to bacteriocin treatment. This may have direct implica-
tions on the elucidation of probable mechanisms for cell
adaptation as well as the development of bacteriocin
resistance mechanisms. Moreover, a better knowledge of
the bacterial response to enterocin AS-48 may also allow
identification of new targets that could be exploited to
enhance bacteriocin activity. The purpose of the present
study was to determine the genome-wide response of B.
cereus  cells exposed to enterocin AS-48 and to identify
components that help the bacterium to survive bacteri-
ocin treatments.
Results
Effect of enterocin AS-48 on global gene expression in B. 
cereus ATCC14579
Enterocin AS-48 was shown to inhibit growth of vegeta-
tive cells and spore outgrowth of B. cereus [12] and it can
be an effective bioagent against B. cereus in various food
related media, e.g. hard cheese, rice based foods, fruit and
vegetable juices [13-15]. Although the mode of action of
AS-48 is well understood, the response of bacteria to ente-
rocin AS-48 is poorly examined. We have therefore deter-
mined the transcriptome of B. cereus ATCC14579 in
response to AS-48. To omit the effect of growth inhibition
related differences between the treated and the control
culture, a subinhibitory bacteriocin concentration of 0.5
μg/ml of AS-48 was used in our experiments. We observed
no adaptation process, when B. cereus was subsequently
cultivated in the presence of 0.5 μg/ml of AS-48, but only
when cells were treated with low, but inhibitory concen-
tration of AS-48 (data not shown). In preliminary experi-
ments samples were taken 15 and 30 min after addition of
AS-48, but we could not detect any significant changes
after 15 min (data not shown), therefore final transcrip-
tome comparisons were performed on samples incubated
with AS-48 for 30 min. Transcriptome analyses were per-
formed on six independent biological replicates. 20 genes
were identified to be significantly upregulated, and only 4
genes to be downregulated (Table 1). All 4 downregulatedBMC Microbiology 2009, 9:227 http://www.biomedcentral.com/1471-2180/9/227
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genes (BC0406-BC0409) are located in one putative
operon, coding for proteins involved in arginine and pro-
line metabolism. Most of the upregulated genes code for
proteins located in the membrane (highlighted in bold in
Table 1) or contain a signal sequence or periplasmic
domain. The putative membrane proteins show similarity
to different transport or permease proteins or have been
annotated as a hypothetical protein with no known func-
tion. Two regulators belonging to the PadR family were
significantly upregulated, both located upstream of, and
in one operon with, genes coding for membrane proteins
that are similarly enhanced during our experiments. Here,
we selected the most upregulated putative operon
(BC4206-4207) for further characterization. The BC4206-
4207 operon is conserved in all fully sequenced B. cereus,
B thuringiensis and B. weihenstephanensis genomes except
in the B. cereus Cytotoxis strain, but is missing in B. anthra-
cis and other Bacillus species. When this operon is found
in a genome, the genes surrounding this operon are also
conserved (Figure 1).
Validation of array experiments
Real-time RT-PCR was performed on independent sam-
ples to validate our array results. To verify that upregula-
tion of the genes were the result of specific treatment with
AS-48 and not a general response, we also applied sam-
ples that were incubated in the presence of sublethal
amount of bacitracin (25 μg/ml) or nisin (2 μg/ml), bac-
teriocins that both affect cell wall biosynthesis through
blocking the lipid II cycle by interaction with C55-isopre-
nyl pyrophosphate [16] or forming pores in cell mem-
brane during interaction with lipid II [17,18], respectively.
Two genes were selected (BC4207 and BC4028), both
coding for a putative membrane protein and both located
Table 1: Summary of transcriptional changes in B. cereus ATCC14579 upon 0.5  g/ml AS-48 treatment
Locus tag Expression ratioa Significance (p-value)b Annotationc Featured
Upregulated
BC4206 8.7 < 10-14 PadR-like transcriptional regulator PR
BC4207 8.7 < 10-14 Hypothetical protein TMS(4)
BC4027 4.7 < 10-14 NADH dehydrogenase subunit N TMS(6)
BC2842 4.0 10-12 Hypothetical protein SS; TMS(2)
BC5438 3.7 10-12 Antiholin-like protein TMS(7)
BC1612 3.7 10-13 Na+/H+ antiporter SS; TMS (11)
BC2300 3.0 10-11 Oxalate/formate antiporter SS; TMS(11)
BC5439 2.7 10-10 Murein hydrolase regulator SS; TMS(4)
BC4528 2.4 10-11 Ferrichrome-binding protein PPD
BC4028 2.4 10-10 NADH dehydrogenase subunit N TMS(6)
BC4268 2.4 10-8 Phosphate transport system 
permease protein
TMS(6)
BC4269 2.3 10-9 Phosphate-binding protein SS
BC4362 2.2 10-7 Ferrichrome transport system 
permease protein
TMS(9)
BC0223 2.2 10-9 Hypothetical protein SS; TMS(1)
BC4029 2.2 10-11 PadR-like transcriptional regulator PR
BC5100 2.1 10-8 Hypothetical protein SS; TMS(1)
BC0383 2.1 10-10 Ferrichrome-binding protein SS, PPD
BC3540 2.1 10-9 BNR-repeat containing protein
BC3541 2.1 10-7 Flavodoxin Flavodoxin
BC0227 2.0 10-9 Hypothetical protein TMS(1)
Downregulated
BC0409 0.3 10-12 Carbamate kinase Kinase
BC0406 0.3 10-12 Arginine deiminase Aminidotransferase
BC0407 0.3 10-12 Ornithine carbamoyltransferase Carbamoyl-P binding domain; Asp/Orn 
binding domain
BC0408 0.3 10-12 Arginine/ornithine antiporter Permease; TMS(1)
a The ratio of gene expression is shown. Ratio: expression in AS-48 treated sample over that in untreated samples.
b Bayesian p value
c Putative function of protein as annotated in the B. cereus ATCC14579 genome sequence
d Domains detected using SMART search http://smart.embl-heidelberg.de/ (Letunic et al., 2006 Nucl Acid Res 34: D257-D260). PR; PadR domain; 
SS, signal sequence; TMS(n), transmembrane segment (n is the number of such domain); PPD, periplasm domain.
Proteins with TMS are highlighted in boldBMC Microbiology 2009, 9:227 http://www.biomedcentral.com/1471-2180/9/227
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downstream of a PadR like regulator (BC4206 and
BC4029, respectively), for quantitative real time RT-PCR.
Quantitative real time PCR showed 26 ± 6 and 18 ± 4
times upregulation of BC4207 and BC4028 in samples
treated with AS-48 compared with control samples,
respectively (Figure 2). Similar analysis of samples treated
with AS-48 for 15 min showed less then 2 times induction
of the BC4207 and BC4028 genes, in agreement with the
lack of significant changes after 15 min of AS-48 treatment
in microarray experiments. Samples incubated in the pres-
ence of bacitracin showed slightly enhanced expression of
target genes, while addition of nisin did not significantly
change the transcription of these genes.
Overexpression of BC4207 increases resistance against AS-
48 in B. cereus and B. subtilis
To resolve whether increased expression of the putative
membrane protein BC4207 helps B. cereus to defend itself
against AS-48, BC4207 was cloned behind the IPTG
inducible Pspac promoter and expression was induced in
B. cereus ATCC14579. After preliminary induction of B.
cereus containing pATK33 using 1 mM of IPTG, cells were
exposed to varying amounts of AS-48 and growth was fol-
lowed in time. As depicted in Table 2, cells containing
overexpressed BC4207 were able to survive in the pres-
ence of slightly increased amounts of AS-48, compared to
cultures containing control plasmid pLM5 or when
BC4207 was not induced. Important to note is that
BC4207 is already expressed in wild type B. cereus in
response to AS-48 explaining the relatively low level of
increased resistance upon further overexpression of
BC4207. Unfortunately, we were not able to obtain a
knockout of BC4207 to show the expected increased sen-
sitivity. To support the idea that the increased resistance of
B. cereus cells against AS-48 is caused by specific overex-
pression of the BC4207 membrane protein, we randomly
selected two membrane proteins (BC4147 and BC4744)
and introduced them into B. cereus ATCC14579 similar to
the BC4207 protein. Expression of these proteins resulted
in no significant growth difference in the presence of var-
ious amounts of AS-48 compared to the strain containing
the pLM5 control plasmid. Further, comparative tran-
scriptome analyses of B. cereus carrying pLM5 control
plasmid and the BC4207 overexpressing plasmid pATK33
in the presence of IPTG revealed the significant (p-value <
10-5) upregulation of the BC4207 gene (13.6 fold) and
downregulation of the BC5171 and BC5073 genes (11.6
fold and 9.3 fold, respectively), when BC4207 was
expressed (data not shown). B. cereus containing pATK33
was challenged with bacitracin and nisin, but expression
of BC4207 did not change the resistance of B. cereus
against these bacteriocins (data not shown).
No gene coding for a BC4207 homologue can be identi-
fied in the fully sequenced genome of B. subtilis 168.
BC4207 was introduced and expressed in B. subtilis with a
similar method used for B. cereus. Upon induction of
BC4207 the sensitivity of B. subtilis was diminished
against AS-48. LiaRS was previously reported to respond
to cell envelope stress and the target gene liaI was highly
upregulated by LiaR in response to the addition of baci-
tracin or nisin to the medium [19]. To see, whether the
presence of AS-48 had similar effects on the expression of
the liaI gene, we have assayed the expression form liaI pro-
moter in response to the addition of AS-48. In contrast to
the high upregulation of liaI in the presence of bacitracin,
we have observed no induction of expression when bacte-
ria were incubated with various amount of AS-48 (data
not shown).
Discussion
In the present study a sublethal AS-48 concentration was
used to detect gene expression differences in B. cereus
ATCC14579 that result from interaction of AS-48 with the
cells, but not in response to cell death induced by AS-48.
We aimed to determine which genes help B. cereus to sur-
vive confrontation with AS-48 and identify possible resist-
ance mechanisms. While there was very mild change in
the growth after 30 min. incubation with a sublethal bac-
teriocin concentration, at least 24 genes were affected sig-
nificantly (Table 1). The observed changes in gene
expression were mostly related to up-regulation of mem-
Conservation of BC4206-BC4207 operon and surrounding  genes in fully sequenced B. cereus, B. thuringiensis and B. wei- henstephanensis species Figure 1
Conservation of BC4206-BC4207 operon and sur-
rounding genes in fully sequenced B. cereus, B. thur-
ingiensis and B. weihenstephanensis species. BC4203-
BC4212 numbers are depicted as genes are labelled in the 
genome of B. cereus ATCC14579. Arrows indicate the 
BC4207 homologue (in grey), PadR homologues (in black), 
conserved proteins with putative function: BC4203, BC4205, 
BC4209 and BC4210 encoding for putative hydrolase, spore 
lyase, lypoate-protA ligase and rhodase, respectively (dashed 
lined), putative conserved regulators: BC4204, BC4211 and 
BC4212 for putative iron dependent repressor, LacI type 
regulator and TetR like regulator, respectively (stripped) and 
other putative genes (in white).
BceATCC14579
BthAlHakam
BthKonkukian
BceE33L
BceATCC10987
BweKBAB4
4207 4208 4209 4210 4211 4212 4203 4204 4205 4206
1kbBMC Microbiology 2009, 9:227 http://www.biomedcentral.com/1471-2180/9/227
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brane associated or periplasmic proteins and downregula-
tion of an operon involved in arginine/ornithine
catabolism. Downregulation of argnine/ornithine meta-
bolic genes might be related to the slight difference in
growth upon AS-48 treatment that is not apparent using
OD measurements. Also, this downregulation might
cause a change in local pH at the cell wall in view of the
decreased catabolic production of NH3 and CO2. Upregu-
lated genes coded for hypothetical membrane proteins or
putative transporters. The BC4206-BC4207 operon was
most heavily upregulated in B. cereus upon AS-48 treat-
ment. BC4206 is PadR type regulator, while BC4207 is a
hypothetical membrane protein with 4 transmembrane
segments. Members of the PadR family are known to have
a function in regulating cellular pathways resulting in
multidrug resistance, virulence or detoxification [20,21].
These proteins involved in resistance mechanisms, are
generally encoded in the vicinity of the padR genes. Over-
expression of the BC4207 protein in both B. cereus and B.
subtilis results in elevated resistance against AS-48. Upon
overexpression of BC4207, we have found no other genes
to be upregulated (data not shown), suggesting that
increase in BC4207 expression alone raised the resistance
of B. cereus against AS-48. Interestingly, enhanced resist-
ance upon BC4207 overexpression was specific to ente-
rocin AS-48 and not observed in the presence of bacitracin
or nisin. Bacitracin and nisin both effect cell wall biosyn-
thesis through blocking the lipid II cycle [16] and forming
pores in the cell membrane during interaction with lipid
II [17,18], respectively. This is not the case of enterocin
AS-48, since the primary action of this antimicrobial pep-
tide, like most other bacteriocins, is the disruption of the
cytoplasmic membrane.
In spite of recent advances on genome and transcriptome
analysis, there are very few reports on the effects of anti-
microbial substances on bacterial gene expression.
Recently, Martínez et al. (2007) [22] reported that lacto-
coccin 972 (Lcn972) significantly upregulated the expres-
sion of 26 genes in Lactococcus lactis, most of which
encode membrane proteins of unknown function and the
two component system (TCS) CesSR (formerly known as
TCS-D) associated with cell-envelope stress. Lcn972 is a
non pore-forming bacteriocin that inhibits the synthesis
of peptidoglycan at the septum in Lactococcus lactis. More-
over, the response of a number of Gram-positive bacterial
species towards cell wall active antibiotics has been stud-
ied recently by using genome-wide transcription analysis
[19,23-27]. Essentially, these reports describe a very com-
plex system involving the concerted action of extracellular
sigma factors and two-component systems (TCSs) [28].
LiaRS, the B. subtilis homologue of CesSR, was unable to
activate liaI expression in B. subtilis in response to AS-48
treatment. Therefore, the effect of AS-48 on bacterial gene
expression clearly differs from the mechanisms described
earlier for B. subtilis [28].
The precise way in which BC4206 responds to the pres-
ence of AS-48 needs to be deciphered by further experi-
mental work, including determining the target genes of
BC4206 and the exact signal sensed by this PadR-type reg-
ulator. The structure and function of the BC4207 mem-
brane protein and its role in the resistance mechanism
against AS-48 is also particularly intriguing and target of
our future research.
Conclusion
B. cereus cells, when treated with bacteriocin AS-48,
increase the expression of the BC4207 gene coding for a
RT-qPCR detection of B. cereus BC4207 and BC4028 genes Figure 2
RT-qPCR detection of B. cereus BC4207 and BC4028 
genes. Relative expressions of BC4207 (grey bars) and 
BC4028 (white bars) were determined in AS-48, bacitracin 
and nisin treated B. cereus ATCC14579 cultures (see Meth-
ods for concentrations). Transcript levels of genes were nor-
malized to the level of house keeping rpoA gene and 
compared to untreated samples (dashed line).
0
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Table 2: Growth inhibition of B. cereus ATCC14579 and B. subtilis 
168 strains containing BC4207 expression plasmid pATK33 or 
control plasmid pLM5 in the presence of various AS-48 
concentrations.
Strain IPTGa MICb
B. cereus ATCC14579 pLM5 - 2.5
+2 . 5
pATK33 - 2.5
+4 . 5 *
B. subtilis 168 pLM5 - 1.0
+1 . 0
pATK33 - 1.5
+5 . 0 *
(a) Cells were growth in the absence (-) or presence (+) of IPTG 
(bold).
(b) Minimal inhibitory concentrations are given in μg/ml of AS-48.
* p-value < 0.005; > 6 cultures as determined with Student's t-test.BMC Microbiology 2009, 9:227 http://www.biomedcentral.com/1471-2180/9/227
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putative membrane protein. Targeted inactivation of the
BC4207 protein might be useful to increase the effect of
AS-48 on food poisoning B. cereus cells.
Methods
Bacterial strains, growth conditions and preparation of 
cells for RNA isolation
Bacillus cereus ATCC 14579 and B. subtilis 168 strains from
glycerol stocks were grown overnight on TY broth at 30°C,
with shaking at 225 rpm. Cultures were diluted to a final
OD600 of 0.15 in fresh TY medium. B. cereus ATCC14579
and B. subtilis 168 strains containing pATK33 or pLM5
were grown in the presence of 50 and 10 μg/ml of kan-
amycin, respectively.
Growth of B. cereus and B. subtilis in the presence of vari-
ous concentration of bacteriocin was monitored every 15
minutes using a TECAN GENios Absorbance Reader
(TECAN).
When cultures reached an OD600 of 0.3, purified enterocin
AS-48 was added to the cultures at a concentration of 0.5
μg/ml, which was the maximal concentration not inhibit-
ing growth, cells were harvested after 15 or 30 min by cen-
trifugation and cell pellets were immediately frozen in
liquid nitrogen and stored at -80°C until RNA isolation.
Six independent biological replicates were used for micro-
array analysis. For quantitative RT-PCR, cells were treated
with nisin and bacitracin at a subinhibitory concentration
of 2 μg/ml and 25 μg/ml, respectively.
Purification of AS-48
Enterocin AS-48 was purified to homogeneity by reversed-
phase high-performance chromatography as described
elsewhere [29].
RNA isolation
RNA extraction was performed with the Macaloid/Roche
method [30] with 2 additional steps of phenol-chloro-
form washing. Purified RNA concentration was measured
using a Nanodrop spectrophotometer at 260 nm. The
quality of purified RNA was checked with a 50 ng/μl sam-
ple by using a BioAnalyser.
DNA-microarray analysis
DNA-microarrays containing amplicons of 5200 anno-
tated genes in the genome of B. cereus ATCC 14579 were
designed and produced as described previously [31]. Slide
spotting, slide treatment after spotting, and slide quality
control were performed as described elsewhere [30].
Data were analysed essentially as described before [32].
Each ORF is represented by duplicate spots on the array.
After hybridization, fluorescent signals were quantified
with the ArrayPro analyser, and processed with Micro-
Prep [31]. Statistical analysis was performed using CyberT
[33]. Genes with a Bayes P-value below 1.0 × 10-4 with at
least twofold differential expression were considered to be
significantly affected. Microarray data has been deposited
in Gene Expression Omnibus database (GSM412591).
Quantitative RT-PCR
Following RNA purification, samples were treated with
RNase-free DNase I (Fermentas) for 60 min at 37°C in
DNaseI buffer (10 mmol·l-1  Tris·HCl (pH7.5), 2.5
mmol·l-1  MgCl2, 0.1 mmol·l-1  CaCl2). Samples were
purified with the Roche RNA isolation Kit. Reverse tran-
scription was performed with 50 pmol random nonamers
on 1 μg of total RNA using RevertAid™ H Minus M-MuLV
Reverse Transcriptase (Fermentas). Quantification of
cDNA was performed on an iCycler iQ (BioRad) using iQ
SYBR Green Supermix. The following primers were used:
for BC4207, qBCE5 (5'-GAGCAACAAATGGAAGAACTG-
3') and qBCE6 (5'-TGTTTGAGTTGGTAAAGCTG-3'), for
BC4028 qBCE7 (5'-CTCCATTTAATTGAGGGTGAG-3')
and qBCE8 (5'-GTTTCCTGTCTATCTCTTTCCA-3') and for
rpoA gene of B. cereus, qBCE3 (5'-CGTGGATATGGTAC-
TACTTTGG-3') and qBCE4 (5'-TTCTACTACGCCCT-
CAACTG-3'). The amount of BC4207 and BC4028 cDNA
was normalized to the level of rpoA cDNA using the 2-ΔΔCt
method [34].
Overexpression of the BC4207, BC4147 and BC4744 
proteins
BC4207, BC4147 and BC4744 genes were amplified with
oMJGB3 (5'-GATCGAAGCTTACGGTAAATAACTTATTA-
CAG-3') and oMJGB4 (5'-GATCCAGGCATGCTCACGT-
CAACAATTAACTTT-3'), oBCE9 (5'-CATATAGGAG TAAT
GATATG-3') and oBCE10 (5'-AGAGAAGATACGGC AT
AG-3'), oBCE11 (5'-TACAAGGAGTTGCTTTATGG-3') and
oBCE11 (5'-TTATATCGGCG CAA CTAC-3'), respectively.
PCR products were cloned into the Eco47III site of pLM5
vector [35], resulting in pATK33, pATK49 and pATK411,
respectively. Plasmids were introduced into the B. cereus
ATCC14579 and B. subtilis 168 strains by electroporation
[36] and natural transformation [37], respectively. IPTG
was used at a final concentration of 1 mM to induce the
overexpression of proteins.
Biological activity
Antimicrobial activities of bacteriocins were determined
as minimal inhibitory concentration (MIC) values against
various Bacilli following previous practice [38]. Growth
was followed in the presence of various concentrations of
bacteriocin and monitored every 15 minutes using a
TECAN GENios Absorbance Reader (TECAN). Without
bacteriocin addition, the final OD600 values were about
1.1 ± 0.1 for B. cereus, 0.8 ± 0.1 for B. subtilis. All experi-
ments were performed in triplicate. Inhibition curves were
made by plotting OD600 at the end of exponential phaseBMC Microbiology 2009, 9:227 http://www.biomedcentral.com/1471-2180/9/227
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in the case of the non treated strain versus bacteriocin con-
centration. The minimal inhibitory concentration values
were determined from the inhibition curves by interpola-
tion. The lowest concentration of bacteriocin at which less
than 1% of the total increase in the OD600, measured in
the absence of bacteriocin, had occurred, was taken as the
MIC value. The MIC values of AS-48, nisin and bacitracin
for B. cereus ATCC14579 were 2.5 μg/ml, 5 μg/ml and 50
μg/ml, respectively.
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